SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000320017-16-000148
Filing Date
2016-09-15
Accepted
2016-09-15 07:43:52
Documents
8
Period of Report
2016-09-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 09.14.16 a8-k091416.htm 8-K 39774
2 EXHIBIT 5.1 OPINION LETTER exhibit51opinionletter.htm EX-5.1 13847
3 EXHIBIT 10.1 RD SPA exhibit101rdspa.htm EX-10.1 79884
4 EXHIBIT 10.2 ASIA SPA exhibit102asiaspa.htm EX-10.2 158259
5 EXHIBIT 10.3 SPA exhibit103spa.htm EX-10.3 147017
6 EXHIBIT 10.4 RRA exhibit104rra.htm EX-10.4 130881
7 EXHIBIT 99.1 PR 09.15.16 exhibit991pr91516.htm EX-99.1 21062
8 mintzlogoa03.jpg GRAPHIC 13674
  Complete submission text file 0000320017-16-000148.txt   611178
Mailing Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920
Business Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920 908-842-0100
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33650 | Film No.: 161886275
SIC: 8090 Services-Misc Health & Allied Services, NEC